Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Tunca, M.
Right arrow Articles by Gonen, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tunca, M.
Right arrow Articles by Gonen, O.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

The British Journal of Rheumatology, Vol 36, 1005-1008, Copyright © 1997 by British Society for Rheumatology

ORIGINAL PAPERS

The efficacy of interferon alpha on colchicine-resistant familial Mediterranean fever attacks: a pilot study

M Tunca, E Tankurt, H Akbaylar Akpinar, S Akar, N Hizli and O Gonen
Department of Internal Medicine, Dokuz Eylul University School of Medicine, Balcova, Izmir, Turkey.

About a quarter of familial Mediterranean fever (FMF) patients have recurrent painful attacks of polyserositis despite regular colchicine treatment. There is no known alternative drug for colchicine-resistant cases. We had previously observed a patient with FMF whose painful attacks disappeared during the 6 month period of interferon alpha (IFN) treatment for his chronic hepatitis B. The objective of the present study was to investigate the possible beneficial effect of IFN on these episodes. Twenty-one consecutive attacks in seven adult patients with FMF were treated at early onset with IFN, the dosage being 3-10 million I U s.c. Eighteen of the 21 attacks could be halted in a mean time of 3.05 h, while the intensity of abdominal pain remained very low. Observed side-effects were generally mild and acceptable. IFN may be a useful adjunct for the treatment of colchicine-resistant attacks in FMF patients.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 PediatricsHome page
T. Kallinich, D. Haffner, T. Niehues, K. Huss, E. Lainka, U. Neudorf, C. Schaefer, S. Stojanov, C. Timmann, R. Keitzer, et al.
Colchicine Use in Children and Adolescents With Familial Mediterranean Fever: Literature Review and Consensus Statement
Pediatrics, February 1, 2007; 119(2): e474 - e483.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
K Ureten, M Calguneri, A M. Onat, L Ozcakar, I Ertenli, and S Kiraz
Interferon alfa in protracted arthritis of familial Mediterranean fever: a robust alternative for synovectomy
Ann Rheum Dis, November 1, 2004; 63(11): 1527 - 1527.
[Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
G. Grateau
Clinical and genetic aspects of the hereditary periodic fever syndromes
Rheumatology, April 1, 2004; 43(4): 410 - 415.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
I. Touitou, E. Ben-Chetrit, R. Gershoni-Baruch, G. Grateau, D. L. Kastner, I. Kone-Paut, A. Livneh, R. Manna, I. Mansour, H. Ozdogan, et al.
Allogenic bone marrow transplantation: not a treatment yet for familial Mediterranean fever
Blood, July 1, 2003; 102(1): 409 - 409.
[Full Text] [PDF]

Home page
 Ann Rheum DisHome page
K Konstantopoulos, A Kanta, C Deltas, V Atamian, D Mavrogianni, A G Tzioufas, I Kollainis, K Ritis, and H M Moutsopoulos
Familial Mediterranean fever associated pyrin mutations in Greece
Ann Rheum Dis, May 1, 2003; 62(5): 479 - 481.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. Milledge, P. J. Shaw, A. Mansour, S. Williamson, B. Bennetts, T. Roscioli, J. Curtin, and J. Christodoulou
Allogeneic bone marrow transplantation: cure for familial Mediterranean fever
Blood, July 18, 2002; 100(3): 774 - 777.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. P. H. Drenth and J. W. M. van der Meer
Hereditary Periodic Fever
N. Engl. J. Med., December 13, 2001; 345(24): 1748 - 1757.
[Full Text] [PDF]

Home page
 BloodHome page
M. Centola, G. Wood, D. M. Frucht, J. Galon, M. Aringer, C. Farrell, D. W. Kingma, M. E. Horwitz, E. Mansfield, S. M. Holland, et al.
The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators
Blood, May 15, 2000; 95(10): 3223 - 3231.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.